Alpha adrenergic receptor modulators
US9040532B2 · kind B2 · utility
3Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2010 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Dec 13, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are described herein useful for treating diseases and conditions by modulation of one or more alpha adrenergic receptor. The compounds can include a naphthalene, a quinoline, a benzoimidazole or an isoquinoline as a core structure. Methods of making, using and formulating these compounds are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.